SGS Introduces the Cobas 6000 Analyzer Series - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SGS Introduces the Cobas 6000 Analyzer Series


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 7

SGS Life Science Services has acquired a Cobas 6000 Analyzer System, chemistry module, for use at its Poitiers, France laboratory. This platform allows the determination of a large number of biological parameters (biomarkers) and metabolites, in as little as two minutes, with precision and reliability, using very small sample volumes.

Employing the concept of "open" technology, the Cobas 6000 provides for easy-to-use reagents as well as those not provided by the manufacturer. This promotes the optimization of protocols and allows SGS to offer additional tests that can be validated based upon the company’s expertise. In order to meet the requirements of bioanalytical Good Laboratory Practice (GLP), all results are entered directly into the Watson Laboratory Information Management System for traceability of analysis and can be grouped by patient, even if the results are obtained during long-term kinetics.

Source: SGS Life Science Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here